![Neil Desai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 7 M $ in data 30/09/2026
Neil P.
Desai is the founder of Aadi Subsidiary, Inc., founded in 2011, serving as Executive Chairman since 2023.
Dr. Desai is currently Director at Whitehawk Therapeutics, Inc. since 2024.
Former positions include Director at Mercator MedSystems, Inc., Vice President-Strategic Platforms at Celgene Corp.
from 2010 to 2016, Senior Research Scientist at American Bioscience, Inc. from 1991 to 1994, Senior VP-Global Research & Development at Abraxis BioScience, Inc. from 2008 to 2010, and Vice President-Research & Development at Abraxis BioScience, Inc. from 1999 to 2008.
Education includes graduate and doctorate degrees from The University of Texas at Austin and an undergraduate degree from the Institute of Chemical Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2026 | 1.811.241 ( 3,84% ) | 7 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/10/2024 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Fondatore | 01/10/2011 |
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/10/2016 |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/10/2010 |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Direttore Tecnico/Scientifico/R&S | 01/10/2008 |
Mercator MedSystems, Inc.
 Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Develops medical injection devices | Direttore/Membro del Consiglio | - |
American Bioscience, Inc.
 American Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
American Bioscience, Inc.
American Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mercator MedSystems, Inc.
Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Develops medical injection devices | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products | Health Technology |
Institute of Chemical Technology
 Institute of Chemical Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
